Related references
Note: Only part of the references are listed.Overexpression of Forkhead Box M1 Transcription Factor (FOXM1) is a Potential Prognostic Marker and Enhances Chemoresistance for Docetaxel in Gastric Cancer
Kaoru Okada et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients
Yu Wang et al.
LUNG CANCER (2013)
Latest research and treatment of advanced-stage epithelial ovarian cancer
Robert L. Coleman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
FoxM1 Is Associated with Poor Prognosis of Non-Small Cell Lung Cancer Patients through Promoting Tumor Metastasis
Nuo Xu et al.
PLOS ONE (2013)
Involvement of FoxM1 in Non-Small Cell Lung Cancer Recurrence
Nuo Xu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
Samar Masoumi Moghaddam et al.
CANCER AND METASTASIS REVIEWS (2012)
Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma
Yi-Jun Xue et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Genome-Wide Expression Analysis of Middle Eastern Colorectal Cancer Reveals FOXM1 as a Novel Target for Cancer Therapy
Shahab Uddin et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Matrix metalloproteinases in tumorigenesis: an evolving paradigm
Hui Hua et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells
Gabriel T. M. Lok et al.
PLOS ONE (2011)
被撤回的出版物: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors (Retracted article. See vol. 158, pg. 607, 2016)
Aamir Ahmad et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
A new target for proteasome inhibitors: FoxM1
Andrei L. Gartel
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Critical Role and Regulation of Transcription Factor FoxM1 in Human Gastric Cancer Angiogenesis and Progression
Qiang Li et al.
CANCER RESEARCH (2009)
Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis
D. W. Chan et al.
JOURNAL OF PATHOLOGY (2008)
被撤回的出版物: Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells (Retracted article. See vol. 78, pg. 5470, 2018)
Zhiwei Wang et al.
CANCER RESEARCH (2007)
VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis
S Hirakawa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
FoxM1 is required for execution of the mitotic programme and chromosome stability
J Laoukili et al.
NATURE CELL BIOLOGY (2005)
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
H Gerhardt et al.
JOURNAL OF CELL BIOLOGY (2003)
Matrix metalloproteinases in cancer:: Prognostic markers and therapeutic targets
P Vihinen et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Share Paper
